Combined form of Charcot disease and osteomalacia

1929 ◽  
Vol 25 (9) ◽  
pp. 966-968
Author(s):  
I. В. Grossman

Amyotrophic lateral sclerosis, described for the first time in 1869 - 1874 by Charcot and Joffrois and which received more accurate and complete coverage in the future thanks to the studies of Flсhsig, is known to be characterized by primary systemic degeneration along the cortical-muscular pathway, including here, in addition to the spinal cord department, and bulbar, related to the muscles of the face, tongue, soft palate, etc.; the entire conductive path is not always captured, but only a significant part of it

2008 ◽  
Vol 75 (6) ◽  
pp. 2511-2520 ◽  
Author(s):  
Andrea Malaspina ◽  
Narendra Kaushik ◽  
Jackie de Belleroche

2015 ◽  
Vol 35 (14) ◽  
pp. 2385-2399 ◽  
Author(s):  
Nadine Bakkar ◽  
Arianna Kousari ◽  
Tina Kovalik ◽  
Yang Li ◽  
Robert Bowser

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the selective loss of motor neurons. Various factors contribute to the disease, including RNA binding protein dysregulation and oxidative stress, but their exact role in pathogenic mechanisms remains unclear. We have recently linked another RNA binding protein, RBM45, to ALS via increased levels of protein in the cerebrospinal fluid of ALS patients and its localization to cytoplasmic inclusions in ALS motor neurons. Here we show RBM45 nuclear exit in ALS spinal cord motor neurons compared to controls, a phenotype recapitulatedin vitroin motor neurons treated with oxidative stressors. We find that RBM45 binds and stabilizes KEAP1, the inhibitor of the antioxidant response transcription factor NRF2. ALS lumbar spinal cord lysates similarly show increased cytoplasmic binding of KEAP1 and RBM45. Binding of RBM45 to KEAP1 impedes the protective antioxidant response, thus contributing to oxidative stress-induced cellular toxicity. Our findings thus describe a novel link between a mislocalized RNA binding protein implicated in ALS (RBM45) and dysregulation of the neuroprotective antioxidant response seen in the disease.


2018 ◽  
Vol 28 (3) ◽  
pp. 422-426 ◽  
Author(s):  
Satoru Morimoto ◽  
Hiroyuki Hatsuta ◽  
Rie Motoyama ◽  
Yasumasa Kokubo ◽  
Hiroyuki Ishiura ◽  
...  

Synapse ◽  
2002 ◽  
Vol 45 (4) ◽  
pp. 245-249 ◽  
Author(s):  
Masahiko Tomiyama ◽  
Rafael Rodríguez-Puertas ◽  
Roser Cortés ◽  
Angel Pazos ◽  
José M. Palacios ◽  
...  

PLoS ONE ◽  
2017 ◽  
Vol 12 (9) ◽  
pp. e0184384 ◽  
Author(s):  
Edward Pokrishevsky ◽  
Ran Ha Hong ◽  
Ian R. Mackenzie ◽  
Neil R. Cashman

2017 ◽  
Vol 370 (3) ◽  
pp. 391-401 ◽  
Author(s):  
Marcie Jiménez-Riani ◽  
Pablo Díaz-Amarilla ◽  
Eugenia Isasi ◽  
Gabriela Casanova ◽  
Luis Barbeito ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document